225 related articles for article (PubMed ID: 26689956)
1. Concordance of HIV-1 RNA Values by Amplicor and TaqMan 2.0 in Patients With Confirmed Suppression in Clinical Trials.
Garner W; White K; Szwarcberg J; McCallister S; Zhong L; Wulfsohn M
Clin Infect Dis; 2016 Apr; 62(7):929-934. PubMed ID: 26689956
[TBL] [Abstract][Full Text] [Related]
2. Improved Performance of COBAS AmpliPrep/COBAS TaqMan Version 2.0 Assay Over Amplicor Monitor Version 1.5 in the Quantification of HIV-1 RNA Viral Load in Abuja, Nigeria.
Abubakar A; Ndembi N; Ogbanufe O; Inalegwu A; Wilson S; Ebagua I; Peters S; Chime C; Dakum P; Abimiku AG
Curr HIV Res; 2015; 13(4):262-7. PubMed ID: 25613132
[TBL] [Abstract][Full Text] [Related]
3. Establishing diagnostic cut-off criteria for the COBAS AmpliPrep/COBAS TaqMan HIV-1 Qualitative test through validation against the Amplicor DNA test v1.5 for infant diagnosis using dried blood spots.
Maritz J; Preiser W; van Zyl GU
J Clin Virol; 2012 Feb; 53(2):106-9. PubMed ID: 22196872
[TBL] [Abstract][Full Text] [Related]
4. Increased reporting of detectable plasma HIV-1 RNA levels at the critical threshold of 50 copies per milliliter with the Taqman assay in comparison to the Amplicor assay.
Lima V; Harrigan R; Montaner JS
J Acquir Immune Defic Syndr; 2009 May; 51(1):3-6. PubMed ID: 19247185
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of the Cobas Amplicor HIV-1 Monitor Ultrasensitive Test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples.
Berger A; Scherzed L; Stürmer M; Preiser W; Doerr HW; Rabenau HF
J Clin Virol; 2005 May; 33(1):43-51. PubMed ID: 15797364
[TBL] [Abstract][Full Text] [Related]
6. Fully automated quantification of human immunodeficiency virus (HIV) type 1 RNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan system.
Schumacher W; Frick E; Kauselmann M; Maier-Hoyle V; van der Vliet R; Babiel R
J Clin Virol; 2007 Apr; 38(4):304-12. PubMed ID: 17329164
[TBL] [Abstract][Full Text] [Related]
7. High correlation between the Roche COBAS® AmpliPrep/COBAS® TaqMan® HIV-1, v2.0 and the Abbott m2000 RealTime HIV-1 assays for quantification of viral load in HIV-1 B and non-B subtypes.
Karasi JC; Dziezuk F; Quennery L; Förster S; Reischl U; Colucci G; Schoener D; Seguin-Devaux C; Schmit JC
J Clin Virol; 2011 Nov; 52(3):181-6. PubMed ID: 21813320
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test and identification of rare polymorphisms potentially affecting assay performance.
Pyne MT; Brown KL; Hillyard DR
J Clin Microbiol; 2010 Aug; 48(8):2852-8. PubMed ID: 20573864
[TBL] [Abstract][Full Text] [Related]
9. Comparative frequencies of HIV low-level viremia between real-time viral load assays at clinically relevant thresholds.
Do T; Duncan J; Butcher A; Liegler T
J Clin Virol; 2011 Dec; 52 Suppl 1():S83-9. PubMed ID: 21995930
[TBL] [Abstract][Full Text] [Related]
10. [Utilities and limitations of a real-time PCR based assay for HIV-1 RNA quantification].
Yotsumoto M; Yamamoto Y; Amano K; Fukutake K
Rinsho Byori; 2010 Feb; 58(2):124-30. PubMed ID: 20229810
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test: comparison with the Cobas Amplicor HIV-1 Monitor test (manual specimen preparation).
Berger A; Scherzed L; Stürmer M; Preiser W; Doerr HW; Rabenau HF
J Clin Virol; 2002 Dec; 25 Suppl 3():S103-7. PubMed ID: 12467784
[TBL] [Abstract][Full Text] [Related]
12. Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level.
Taylor N; Grabmeier-Pfistershammer K; Egle A; Greil R; Rieger A; Ledergerber B; Oberkofler H
PLoS One; 2013; 8(8):e74024. PubMed ID: 24023696
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive comparison of the VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 MONITOR 1.5 assays on 1,000 clinical specimens.
Galli R; Merrick L; Friesenhahn M; Ziermann R
J Clin Virol; 2005 Dec; 34(4):245-52. PubMed ID: 16286047
[TBL] [Abstract][Full Text] [Related]
14. Low-level viremia associated with the use of TaqMan assay.
Szabo S; Moffett LE; Cantwell-McNelis K; James CW; Joseph A
J Int Assoc Physicians AIDS Care (Chic); 2010; 9(4):203-5. PubMed ID: 20530465
[TBL] [Abstract][Full Text] [Related]
15. Ability of two commercially available assays (Abbott RealTime HIV-1 and Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 Version 2.0) to quantify low HIV-1 RNA Levels (<1,000 copies/milliliter): comparison with clinical samples and NIBSC working reagent for nucleic acid testing assays.
Amendola A; Marsella P; Bloisi M; Forbici F; Angeletti C; Capobianchi MR
J Clin Microbiol; 2014 Jun; 52(6):2019-26. PubMed ID: 24671791
[TBL] [Abstract][Full Text] [Related]
16. The significance of low-level plasma HIV viral load on COBAS TaqMan HIV-1 assays for patients with undetectable plasma viral load on COBAS Amplicor monitor version 1.5.
Manavi K
HIV Clin Trials; 2008; 9(4):283-6. PubMed ID: 18753122
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of a new real-time PCR assay kit for quantification of human immunodeficiency virus RNA in plasma].
Sudo K; Shima T; Kondo M; Kato S; Mitsunobu I
Kansenshogaku Zasshi; 2007 Jan; 81(1):1-5. PubMed ID: 17338309
[TBL] [Abstract][Full Text] [Related]
18. Measurement of plasma HIV-1 RNA below the limit of quantification (<20 copies/mL) of commercial assays with the integrase HIV RNA single-copy assay.
Margot N; Koontz D; McCallister S; Mellors JW; Callebaut C
J Clin Virol; 2018 Nov; 108():50-52. PubMed ID: 30240941
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays.
Damond F; Roquebert B; Bénard A; Collin G; Miceli M; Yéni P; Brun-Vezinet F; Descamps D
J Clin Microbiol; 2007 Oct; 45(10):3436-8. PubMed ID: 17715371
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Three Different FDA-Approved Plasma HIV-1 RNA Assay Platforms Confirms the Virologic Failure Endpoint of 200 Copies per Milliliter Despite Improved Assay Sensitivity.
Lalama CM; Jennings C; Johnson VA; Coombs RW; McKinnon JE; Bremer JW; Cobb BR; Cloherty GA; Mellors JW; Ribaudo HJ;
J Clin Microbiol; 2015 Aug; 53(8):2659-66. PubMed ID: 26063861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
